• LAST PRICE
    0.3700
  • TODAY'S CHANGE (%)
    Trending Down-0.0080 (-2.1164%)
  • Bid / Lots
    0.3700/ 34
  • Ask / Lots
    0.3733/ 6
  • Open / Previous Close
    0.3750 / 0.3780
  • Day Range
    Low 0.3628
    High 0.3768
  • 52 Week Range
    Low 0.1620
    High 1.7169
  • Volume
    578,327
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 0.378
TimeVolumeICU
09:32 ET113970.375
09:34 ET188570.37515
09:36 ET150000.3701
09:38 ET287500.3734
09:39 ET175000.370201
09:41 ET12000.3768
09:43 ET15000.3768
09:45 ET8000.3768
09:48 ET124790.3762
09:50 ET339560.3767
09:54 ET25730.3768
09:56 ET5500.3703
09:59 ET9000.373549
10:01 ET164510.3768
10:06 ET1000.3768
10:08 ET4000.3768
10:14 ET1990.3725
10:15 ET1000.3734
10:17 ET5660.373
10:19 ET278520.365
10:21 ET20000.3699
10:24 ET88400.3661
10:26 ET36760.3661
10:28 ET31620.365
10:30 ET23500.365
10:32 ET99700.364
10:33 ET237000.3697
10:35 ET1240.365047
10:37 ET2000.3694
10:39 ET2730.365
10:42 ET15190.3697
10:44 ET3000.369
10:46 ET19470.3696
10:48 ET18160.3696
10:51 ET21210.3695
10:53 ET1000.3673
10:55 ET40580.3665
10:57 ET3990.3643
11:00 ET2000.365
11:02 ET7580.365
11:04 ET5000.3699
11:06 ET8000.366
11:09 ET123230.367
11:11 ET4220.368149
11:13 ET24250.3664
11:18 ET2250.3665
11:20 ET1490.3681
11:22 ET209000.366773
11:24 ET23410.3666
11:26 ET22000.3665
11:29 ET19530.3699
11:31 ET3900.3682
11:33 ET5800.3674
11:40 ET36650.3682
11:42 ET101800.3699
11:44 ET17000.3699
11:45 ET5990.37
11:47 ET7920.3704
11:49 ET14200.3669
11:51 ET1000.3704
11:54 ET30350.37
11:56 ET3000.37
12:02 ET7000.366701
12:03 ET300190.37
12:05 ET1000.37
12:07 ET1700.3699
12:12 ET65820.3715
12:18 ET16230.3675
12:20 ET2250.3736
12:21 ET4000.3701
12:27 ET10000.3736
12:30 ET5000.3666
12:34 ET16430.3704
12:36 ET4630.3685
12:38 ET10000.3685
12:39 ET8230.3704
12:45 ET109810.368701
12:48 ET6020.37
12:52 ET3900.3686
12:54 ET36330.366658
12:56 ET1000.3683
12:59 ET4720.369337
01:01 ET2700.3696
01:03 ET25400.37
01:06 ET11000.37
01:08 ET107440.3737
01:10 ET12250.3737
01:12 ET1000.3737
01:17 ET3000.3736
01:19 ET1200.37
01:21 ET6090.3733
01:24 ET1000.3733
01:26 ET40000.3734
01:28 ET51000.3734
01:33 ET100000.37
01:37 ET22000.3734
01:39 ET62000.37
01:42 ET13500.3702
01:44 ET68500.3734
01:46 ET3500.3671
01:48 ET2000.371889
01:50 ET2000.3733
02:04 ET1000.3733
02:11 ET52840.3732
02:13 ET27000.3716
02:15 ET20000.3716
02:20 ET59630.3716
02:22 ET2300.3701
02:24 ET2000.3701
02:29 ET2840.37175
02:38 ET52720.3734
02:49 ET27860.3726
02:51 ET6000.3747
02:54 ET3000.3746
02:56 ET13130.3747
02:58 ET10000.3704
03:00 ET507850.3734
03:03 ET13200.3711
03:05 ET1000.3665
03:16 ET8010.3664
03:18 ET4000.3691
03:20 ET67990.37
03:21 ET22090.37
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesICU
SeaStar Medical Holding Corp
28.5M
-0.3x
---
United StatesCQCQ
MakingORG Inc
26.7M
-229.4x
---
United StatesFEMY
Femasys Inc
27.6M
-1.5x
---
United StatesBIAF
bioAffinity Technologies Inc
28.7M
-2.9x
---
United StatesFDIT
BioRegenx Inc
25.8M
-18.4x
---
United StatesRMSL
REMSleep Holdings Inc
22.9M
-13.7x
---
As of 2024-05-24

Company Information

SeaStar Medical Holding Corporation is a commercial-stage medical technology company. The Company is focused on developing extracorporeal therapies to reduce the consequences of hyperinflammation on vital organs. The Company's technologies rely on science to provide life-saving solutions to critically ill patients. The Company develops and commercializes cell-directed extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company uses its Selective Cytopheretic Device (SCD) technology platform to clinically validate several acute organ injury indications, including kidneys and lungs. Its investigational SCD is an extracorporeal synthetic membrane device designed to integrate into existing continuous renal replacement therapy (CRRT) systems that are commonly installed in hospitals throughout the United States.

Contact Information

Headquarters
3513 Brighton Blvd, Suite 410DENVER, CO, United States 80216
Phone
813-362-6488
Fax
302-655-5049

Executives

Independent Chairman of the Board
Richard Barnett
Chief Operating Officer, Director
Eric Schlorff
Chief Financial Officer
David Green
Vice President - Finance
Caryl Baron
Chief Medical Officer
Kevin Chung

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$28.5M
Revenue (TTM)
$0.00
Shares Outstanding
75.4M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-1.07
Book Value
$-0.29
P/E Ratio
-0.3x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.